Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07816900) titled 'Efficacy and Safety of Da-Cheng-Qi Decoction in Severe Acute Pancreatitis' on Sept. 8.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
Primary Sponsor: Shanghai Jiao Tong University School of Medicine
Condition:
Severe Acute Pancreatitis
Intra-abdominal Hypertension
Intervention:
Drug: Da-Cheng-Qi Decoction Plus Standard Western Treatment
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: April 1, 2026
Target Sample Size: 60
Countries of Recruitment:
China
To know ...